LONDON: Drugmaker AstraZeneca struck a deal on Saturday (Sunday in Manila) to supply up to 400 million doses of an experimental coronavirus disease 2019 (Covid-19) vaccine to European Union (EU) countries, the latest in a series of agreements as scientists, governments and pharmaceutical companies race to combat the virus.

AstraZeneca plans to begin delivering the vaccine to European countries by the end of this year under the agreement with the Inclusive Vaccine Alliance, formed this month by France, Germany, Italy and the Netherlands. All other EU member-states will have the chance to take part under the same terms as the original alliance members.

Premium + Digital Edition

Ad-free access


P 80 per month
(billed annually at P 960)
  • Unlimited ad-free access to website articles
  • Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)

TRY FREE FOR 14 DAYS
See details
See details